Matching-adjusted indirect treatment comparison of liso-cel versus axi-cel in relapsed or refractory large B cell lymphoma

Overview of attention for article published in Journal of Hematology & Oncology, September 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

So far, Altmetric has seen 9 X posts from 8 X users, with an upper bound of 12,467 followers.

RT @CARTTherapy: Matching-adjusted indirect treatment comparison of liso-cel versus axi-cel in relapsed or refractory large B cell l… https…

RT @CARTTherapy: Matching-adjusted indirect treatment comparison of liso-cel versus axi-cel in relapsed or refractory large B cell l… https…

RT @CARTTherapy: Matching-adjusted indirect treatment comparison of liso-cel versus axi-cel in relapsed or refractory large B cell l… https…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.